
Rudra Pratap Singh
In a groundbreaking initiative set to redefine ophthalmology, Zeiss India has partnered with the Indian Institute of Science (IISc) to establish an advanced AI-driven research lab at the IISc campus. This collaboration aims to harness artificial intelligence to improve early diagnosis, personalize treatment, and enhance accessibility in eye care solutions.
Building the Future of Eyecare with AI
The research lab, which is part of Zeiss India’s corporate social responsibility (CSR) initiative, will be equipped with state-of-the-art IT infrastructure and will support Master’s and PhD students in their research. “We will sponsor these students. Currently, we have two Master’s students enrolled, and we are looking for two PhD students,” says Ashish Modi, Head of the Centre of Application Research India (Zeiss India’s R&D Division). The plan is to have around 8-10 researchers working in the lab over the next three years.
Creating a Robust Eyecare Database
One of the lab’s primary objectives is to develop a comprehensive dataset for conditions such as glaucoma and diabetic retinopathy, two leading causes of blindness. By leveraging AI, researchers aim to facilitate early screening and intervention for these conditions. Additionally, the lab will explore AI’s potential in identifying age-related cognitive impairment through ophthalmological data.
Beyond research, the lab will focus on developing portable, AI-powered diagnostic devices that can be deployed in remote areas. These handheld tools will enable large-scale screenings, significantly reducing the burden on healthcare professionals while expanding access to quality eyecare.
Integrating AI into Healthcare at IISc
The initiative aligns seamlessly with IISc’s vision of integrating clinical research with medical practice. Dr. Rajesh Sundaresan, Dean of the Electrical, Electronics, and Computer Sciences Division at IISc, highlights the importance of this collaboration: “In India, clinical research is often separate from medical practice. Our upcoming medical school and hospital at IISc are an effort to change this. By intertwining AI-enabled healthcare with our technological expertise, we can accelerate advancements in diagnostics and treatment.”
With AI set to revolutionize modern medicine, this partnership between Zeiss India and IISc is poised to make significant contributions to the future of ophthalmology. By combining cutting-edge technology with real-world clinical applications, the initiative promises to make high-quality eyecare more accessible and effective than ever before.